Official websites use. Share sensitive information only on official, secure websites. This work is published and licensed by Dove Medical Press Limited. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
For permission for commercial use of this work, please see paragraphs 4. Pregnant women exhibit COVID vaccine hesitancy due to concerns regarding potential risks to their babies, doubts about vaccine efficacy, and limited access to information.
A cross-sectional study was conducted on pregnant women using a questionnaire covering socio-demographic information, pregnancy-related characteristics, perceptions about the COVID vaccine, and vaccination status. Univariable and multivariable logistic regression analyses were utilized to identify factors associated with the outcome variable. Among the pregnant women who participated in this study, Reasons for not receiving the vaccine included a lack of information about the vaccine Pregnant women in Mogadishu, Somalia, face challenges with sub-optimal covid vaccine uptake.
Implementations should improve awareness of COVID risks and facilitate discussions between healthcare providers and pregnant women. In addition, efforts to provide reliable information about the vaccine, alleviate concerns about its adverse effects, and dispel misconceptions about fertility, menstrual cycles, efficacy, and foetal impact are crucial.
The global impact of COVID has been substantial, contributing significantly to both morbidity and mortality among various populations, particularly vulnerable groups. These vaccines, authorized for emergency use across the globe, have played a crucial role in curbing the spread of the virus and reducing severity and hospitalizations.
